A unique strategy for the possible therapy of AD is the targeted regulation of APP gene expression by the adjustment of 5′-UTR sequence function, as doing so can improve protective brain iron balance and give anti-amyloid efficacy by changing APP translation. The gene discussed is APP; the disease is Alzheimer disease.